Navigation Links
Medspira and Mayo Clinic Enter Into Agreement

MINNEAPOLIS, Nov. 18 /PRNewswire/ -- Medspira, and Mayo Clinic have entered into an agreement to commercialize, manufacture and market several Mayo Clinic developed products and technologies invented by Mayo physicians and scientists. Mayo Clinic technologies included in the license agreement are two Radiology products currently available in the market, the Interactive Breath-Hold Control System and the BC-10 MRI Coils, and two technologies that Medspira will develop further, with the intent of making them commercially available in the next 12-24 months. "Medspira is honored to work with Mayo Clinic where research is a critical part of its commitment to excellence and interdependence in the three areas of research, education and patient care," said Tim Anderson Medspira CEO.

Commercially Available Technologies

The Breath Hold Interactive Breath-Hold Control System is a noninvasive device that enables patients to perform consistent, repeatable breath-holds during diagnostic imaging and image-guided interventional procedures. Respiratory motion and inconsistent patient breath-holds can prevent accurate needle biopsies of small masses in the lung and upper abdomen. Image-guided needle biopsies can be preformed on an outpatient basis, have less complications, are much less invasive to the patient, and are less costly than surgical biopsies. Breath Hold has FDA cleared (Class II, 513(g)) and CE marked (Class I).

Mayo Clinic's BC-10 MRI Coil is designed to allow acquisition of high resolution MRI images of the wrist at 1.5 and 3.0 Tesla. The BC-10's bird cage design provides a level of detail needed to diagnose many problems within the complicated structures of the wrist and hand. Products have FDA cleared (510(k) Class II) and CE marked (Class I).

Technologies Under Development:

New technologies for diagnosis and treatment of fecal incontinence (FI) will help primary care providers, gastroenterologists, colorectal surgeons, and gynecologists care for patients with FI. FI is most common in the elderly and in women after childbirth. Although effective treatments exist, many people and their families have difficulty coping with this embarrassing problem. Because the existing methods for assessing anorectal functions are expensive and not available in primary care clinics, the condition is often untreated, which can lead to isolation, depression or premature admission to a nursing home. This emerging technology promises to simplify diagnostic assessment and facilitate management of fecal incontinence.

Additional technologies to address concerns over the safety of angiograph contrast agents are also in development. Known as a Hemostasis Valve, the technology allows Cardiologists and Radiologists to more safely, quickly and easily perform catheter based procedures. The valves can significantly reduce bleeding. The procedure is accomplished in less time and gives the physician more control over catheter placement than valves currently available in the marketplace.

Mayo Clinic has licensed these technologies through its Office of Intellectual Property to Medspira and will receive royalties from sales. Mayo Clinic also holds an equity position in Medspira.

About Medspira

Medspira was formed by a group of private investors to bring new, clinically inspired technologies to a wider audience for the benefit of patients and physicians. Its highly focused sales model serves the market in both North America and worldwide. These devices represent the first products for the company. For more information, contact Sarah Thornton (

About Mayo Clinic Office of Intellectual Property

Mayo Clinic has one of the most highly evolved intellectual property and technology commercialization efforts in academic medicine, with a 20-year history of supporting Mayo's mission.

The Office of Intellectual Property at Mayo Clinic serves as a bridge between discoveries and the marketplace. The office works with inventors and commercial industry to determine the right fit for each innovation, whether a sponsored research agreement, licensing agreement, technology-based venture, start-up company or entirely new business model. Mayo Clinic's Office of Intellectual Property has filed more than 2,400 patents resulting in over 600 active patent-licensing agreements with business partners in the biomedical and manufacturing industries.

SOURCE Medspira

SOURCE Medspira
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation
2. College Opens Free Dental Hygiene Clinic To Serve The Public
3. News brief: Adverse symptom reporting by patients vs. clinicians
4. Tulane Cancer Center to begin novel clinical trial for late-stage prostate cancer drug
5. Ziosoft Will Showcase New Clinical Functionality and Workflow Optimization Tools for Its Advanced 3D Thin-Client Software at RSNA 2009
6. Department of Health Updates H1N1 Vaccine Distribution Effort, Reminds At-Risk Residents of Upcoming Vaccination Clinics
7. American Heart Association Late Breaking Clinical Trial Report: In Patients on Statins, Raising Good Cholesterol with Niacin, but not Reducing Bad Cholesterol with Ezetimibe, Decreases Plaque Build-Up
8. First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes
9. American Heart Association Late Breaking Clinical Trial Report: Tests Predict Which Patients Are Resistant to Anti-Clotting Therapy During Angioplasty, Stenting
10. Multiple Health Conditions Discovered During Free Clinic for Uninsured People in New Orleans
11. November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for Hemorrhoids, Interactive Video Games Improve Health and Heart Failure Treatments
Post Your Comments:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing an ... to overcome a rare and deadly chromosome abnormality. , After struggling since birth ...
(Date:10/13/2017)... ... 13, 2017 , ... While it’s often important to take certain medications during ... Austin, Texas, has identified a solution. , She developed a prototype for MOTION LIGHT-UP ... such, it eliminates the need to turn on a light when taking medication during ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... IRVING, Texas , Oct. 11, 2017  Caris ... science focused on fulfilling the promise of precision medicine, ... Institute has joined Caris, Precision Oncology Alliance™ (POA) as ... leading cancer centers, the St. Jude Crosson Cancer Institute ... to advance the use of tumor profiling, making cancer ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
Breaking Medicine Technology: